Gene Therapy
for the CNS
The Future, Now
Through next-generation
capsid engineering, Apertura
is unlocking new treatments
for neurological diseases
TfR1 CapX
A next-generation AAV capsid for
IV-to-brain delivery via TfR1.
Advancing to the clinic in 2H 2026